Pharma Journalist -

Pfizer Inc. and BioNTech SE announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of…
Read More...

Gilead Sciences, Inc. announced that the European Commission (EC) has granted Marketing Authorization for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV…
Read More...

Ocelot Bio, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat complications of end-stage liver disease (ESLD), announced…
Read More...

On August 19, 2022, Porton Advanced Solutions (Porton Advanced) announced the completion of its Series B financing round with over US$80Million. Current round of financing was led by…
Read More...

SAE Media Group reports: James Drinkwater is chairing the 2nd Annual Aseptic Processing Conference, taking place on 19–20 September 2022, in London, UK. SAE Media Group proudly…
Read More...

Bristol Myers Squibb announced that it has successfully completed its acquisition of Turning Point Therapeutics, Inc. (“Turning Point”), in an all-cash transaction. With the completion…
Read More...

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for fezolinetant, an investigational oral,…
Read More...

Atomwise announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet platform for computational discovery and research…
Read More...

Celltrion Healthcare announced that the European Commission (EC) has approved Vegzelma (CT-P16), a biosimilar bevacizumab referencing EU-approved Avastin, for the treatment of…
Read More...

Nuance Pharma announces the Center for Drug Evaluation has approved its Investigational New Drug application supporting its pivotal clinical trial of Ensifentrine for the maintenance…
Read More...